Source:http://linkedlifedata.com/resource/pubmed/id/19728787
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-5-26
|
pubmed:abstractText |
Chlorambucil was incorporated into a nanoemulsion modified with poly(ethylene glycol) to improve its pharmacokinetics and tissue distribution, and thus enhance its therapeutic efficacy. A long-circulating nanoemulsion (LNE) was prepared using soybean oil, egg lecithin, cholesterol and PEG(2000)DSPE. The LNE had an oil droplet size <200 nm with a surface charge of -32.2 to -35.6 mV. Approximately, 97% of the chlorambucil was encapsulated in the LNE. Intravenous (i.v.) administration of the chlorambucil LNE to C57 B/6 mice showed improved pharmacokinetic parameters with 1.4-fold higher area under the plasma concentration-time curve (AUC) and 1.3-fold longer half-life compared to a non-PEG-modified nanoemulsion, and 2.7-fold higher AUC and 7.6-fold longer half-life compared to chlorambucil solution. Tissue distribution studies after i.v. administration with LNE showed a considerable decrease in drug uptake in the reticulo-endothelial system containing organs compared to non-PEG-modified nanoemulsion. Additionally, the chlorambucil delivered in LNE significantly enhanced therapeutic efficacy in the subcutaneous colon-38 adenocarcinoma tumor mouse model with no apparent increase in toxicity. This study suggests that LNE could produce remarkably improved pharmacokinetic profile and therapeutic efficacy of chlorambucil compared to non-PEG-modified nanoemulsion and solution.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1029-2330
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-33
|
pubmed:meshHeading |
pubmed-meshheading:19728787-Animals,
pubmed-meshheading:19728787-Antineoplastic Agents, Alkylating,
pubmed-meshheading:19728787-Area Under Curve,
pubmed-meshheading:19728787-Chlorambucil,
pubmed-meshheading:19728787-Colonic Neoplasms,
pubmed-meshheading:19728787-Delayed-Action Preparations,
pubmed-meshheading:19728787-Drug Carriers,
pubmed-meshheading:19728787-Injections, Intravenous,
pubmed-meshheading:19728787-Mice,
pubmed-meshheading:19728787-Molecular Structure,
pubmed-meshheading:19728787-Nanostructures,
pubmed-meshheading:19728787-Neoplasms, Experimental,
pubmed-meshheading:19728787-Tissue Distribution
|
pubmed:year |
2010
|
pubmed:articleTitle |
Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion.
|
pubmed:affiliation |
School of Pharmacy, The University of Auckland, Auckland, New Zealand.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|